N1 Life

N1 Life focuses on developing innovative drug delivery technologies that can improve the efficacy and safety of therapeutic agents for people experiencing severe and untreatable diseases. Traditionally, human tissue complexities have hindered drug development and delivery. Their proprietary platforms, Absotride™ and ChARLSTM, offer enhanced delivery of therapeutic molecules, improving bioavailability and reducing toxicity. Absotride™ Peptide-based Delivery Platform utilizes peptides to enhance the delivery of therapeutic molecules, improving their bioavailability and reducing toxicity. ChARLSTM Polymer-based Delivery Platform leverages polymers to create targeted drug delivery systems, enabling precise delivery of therapeutics to specific tissues and cells. N1 Life is actively collaborating with other companies to explore new applications for their technology platforms.

Jobs: